Literature DB >> 8084487

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.

J J Rutter1, C Gundlah, S B Auerbach.   

Abstract

The effect of prolonged uptake inhibition with fluoxetine (10 mg/kg/day i.p. x 14 days) on extracellular serotonin (5-HT) in the rat diencephalon was monitored using in vivo microdialysis. The increase in extracellular 5-HT after repeated administration of fluoxetine was significantly greater than the increase produced by a single injection of this uptake blocker. This difference may have been due to a decrease in somatodendritic autoreceptor sensitivity, since the response to a low dose of the 5-HT1A agonist 8-OH-DPAT (25 micrograms/kg i.v.) was abolished in the chronic rats, while the response to a high dose (100 micrograms/kg i.v.) was attenuated as compared to animals injected once with fluoxetine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084487     DOI: 10.1016/0304-3940(94)90635-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  29 in total

1.  Serotonin in microdialysate from the mediobasal hypothalamus increases after progesterone administration to estrogen primed macaques.

Authors:  Maria Luisa Centeno; Arubala P Reddy; Lisa J Smith; Rachel L Sanchez; Jessica A Henderson; Nurgul C Salli; David J Hess; Francis K Y Pau; Cynthia L Bethea
Journal:  Eur J Pharmacol       Date:  2006-10-19       Impact factor: 4.432

2.  Delayed Antidepressant Efficacy and the Desensitization Hypothesis.

Authors:  Kathryn G Commons; Sofia E Linnros
Journal:  ACS Chem Neurosci       Date:  2019-03-11       Impact factor: 4.418

3.  Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.

Authors:  G E Duncan; D J Knapp; S W Carson; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

4.  A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol.

Authors:  Berangere Gruwez; Alain Dauphin; Michel Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

5.  Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems.

Authors:  Mariam B Camacho; Warut D Vijitbenjaronk; Thomas J Anastasio
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

6.  5-HT(1A) Receptor Null Mutant Mice Responding Under a Differential-Reinforcement-of-Low-Rate 72-Second Schedule of Reinforcement.

Authors:  Jonah J Scott-McKean; Galen R Wenger; Laurence H Tecott; Alberto C S Costa
Journal:  Open Neuropsychopharmacol J       Date:  2008-01-01

7.  Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.

Authors:  G Sacchetti; M Bernini; A Bianchetti; S Parini; R W Invernizzi; R Samanin
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

8.  Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.

Authors:  Tracy M Felton; Tommy B Kang; Stephan Hjorth; Sidney B Auerbach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-04       Impact factor: 3.000

9.  Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.

Authors:  I Ceglia; S Acconcia; C Fracasso; M Colovic; S Caccia; R W Invernizzi
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

10.  Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey.

Authors:  George M Anderson; Christina S Barr; Stephen Lindell; Amy C Durham; Ilya Shifrovich; J Dee Higley
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.